ERT

Activities: Regulatory

Trending Articles

  1. OINDPs: Nosey about recent developments? OINDPs are a user friendly and efficacious alternative to injectables in several disease areas
  2. Transforming healthcare with patient centricity In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...
  3. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  4. Compact process thermostat for efficient temperature control in the laboratory The temperature control system is designed for the accurate temperature control of small research reactors between -40 to +200 °C
  5. AviadoBio expands presence at Canary Wharf The company has acquired 11,000 sqft of laboratory and office space in Canary Wharf to accommodate the growing team

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

Recruitment

ERT appoints industry veteran to advance eCOA strategy
Regulatory

ERT receives sixth consecutive award for outstanding customer service

Remains committed to exceeding expectations, driving high satisfaction
Regulatory

ERT’s Trial Oversight solution shortlisted for clinical trial award

ERT, a global data and technology company that minimises uncertainty and risk in clinical trials, announced that ERT Trial Oversight — its centralised, cloud-based clinical trial management solution — has been named a finalist for the 2017 Scrip Best Sponsor-Focused Technological Development in Clinical Trials Award
Subscribe now